Stocks and Investing Stocks and Investing
Thu, January 18, 2018
Wed, January 17, 2018
Tue, January 16, 2018
Fri, January 12, 2018
Thu, January 11, 2018
Wed, January 10, 2018
Tue, January 9, 2018
Mon, January 8, 2018
Fri, January 5, 2018
Thu, January 4, 2018
Wed, January 3, 2018
Tue, January 2, 2018

David Lewis Upgraded (ABT) to Buy on, Jan 2nd, 2018


Published on 2024-10-26 01:40:57 - WOPRAI
  Print publication without navigation


David Lewis of Morgan Stanley, Upgraded "Abbott Laboratories" (ABT) to Buy on, Jan 2nd, 2018.

David has made no other calls on ABT in the last 4 months.



There are 3 other peers that have a rating on ABT. Out of the 3 peers that are also analyzing ABT, 1 agrees with David's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Amit Hazan of "Citigroup" Maintained at Hold with Increased Target to $59 on, Thursday, October 19th, 2017


These are the ratings of the 2 analyists that currently disagree with David


  • Joanne Wuensch of "BMO Capital" Upgraded from Hold to Buy and Increased Target to $65 on, Tuesday, December 12th, 2017
  • Matthew Taylor of "Barclays" Maintained at Buy with Increased Target to $64 on, Thursday, October 19th, 2017